Ipilimumab for stage unresectable III/IV melanoma: Brazilian experience in an expanded access program

Category Primary study
JournalJournal of Clinical Oncology
Year 2014
This article has no abstract
Epistemonikos ID: 13dc54e915743273d106ffb42050cb98241971ba
First added on: Feb 06, 2025